Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	46646
Country	Japan

Received	2019-02-20 07:29
Peer-Review Started	2019-02-22 09:02
To Make the First Decision	2019-04-16 06:31
Return for Revision	2019-04-17 08:52
Revised	2019-04-17 12:35
Second Decision	2019-05-27 08:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2019-05-29 17:48
Articles in Press	2019-05-29 17:48
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2019-07-15 07:57
Publish the Manuscript Online	2019-07-15 10:30

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Recent progress of chemotherapy and biomarkers for gastroesophageal cancer
Manuscript Source	Invited Manuscript
All Author List	Osamu Maeda and Yuichi Ando
ORCID	Author(s) ORCID Number Osamu Maeda http://orcid.org/0000-0003-4700-6541 Yuichi Ando http://orcid.org/0000-0002-6849-2297
Funding Agency and Grant Number
Corresponding Author	Osamu Maeda, MD, PhD, Lecturer, Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan. maeda-o@med.nagoya-u.ac.jp
Key Words	Gastroesophageal cancer; Chemotherapy; Biomarker; HER2
Core Tip	This article reviewed the current status and recent developments of gastroesophageal cancer and its related biomarkers for treatment selection. Platinum, fluoropyrimidines, taxanes, irinotecan, trastuzumab and ramucirumab are key drugs. Recently, anti-PD-1 antibodies have become available. PD-L1 expression and microsatellite instability are used to predict the effectiveness of immunotherapy. Genome-wide analysis will provide a better understanding of the biology in gastroesophageal cancer.
Publish Date	2019-07-15 10:30
Citation	Maeda O, Ando Y. Recent progress of chemotherapy and biomarkers for gastroesophageal cancer. World J Gastrointest Oncol 2019; 11(7): 518-526
URL	https://www.wjgnet.com/1948-5204/full/v11/i7/518.htm
DOI	https://dx.doi.org/10.4251/wjgo.v11.i7.518

Full Article (PDF)	WJGO-11-518.pdf
Full Article (Word)	WJGO-11-518.docx
Manuscript File	46646-Review.docx
Answering Reviewers	46646-Answering reviewers.pdf
Audio Core Tip	46646-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	46646-Conflict-of-interest statement.pdf
Copyright License Agreement	46646-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	46646-Language certificate.pdf
Peer-review Report	46646-Peer-review(s).pdf
Scientific Misconduct Check	46646-Scientific misconduct check.pdf
Scientific Editor Work List	46646-Scientific editor work list.pdf